English
简体中文
Total: £ 56.28
Published Date: 2025-06-30 | Pages: 100 | Tables: 95 | Medical Care
The global market for Antiviral Oral Liquid was valued at US$ 3779 million in the year 2024 and is projected to reach a revised size of US$ 4665 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Antiviral Oral liquids are homogeneous liquid preparations, usually contains a solution, an emulsion or a suspension of one or more active ingredients in a suitable liquid base.
The future market trends of antiviral oral liquid are influenced by several factors, such as the emergence of new viral strains, the development of novel drugs, the availability of vaccines, and the consumer demand. Some of the key trends are:
Increased demand for COVID-19 treatment: The ongoing pandemic has boosted the demand for antiviral oral liquid for COVID-19 treatment. Several drugs, such as remdesivir, favipiravir, molnupiravir, and Paxzen have been approved or launched for COVID-19 treatment in different countries. The U.S. government has also invested more than USD 3 billion to accelerate the discovery and development of antiviral oral liquid for COVID-19.
Shift to generic drugs: The patent expiration of some branded antiviral drugs, such as Tamiflu and Valtrex, has opened the market for generic versions of antiviral oral liquid. Generic drugs are cheaper and more accessible than branded drugs, which can increase the market penetration and competition.
Innovation and diversification: The antiviral oral liquid market is expected to witness innovation and diversification in terms of drug class, formulation, indication, and combination therapy. For instance, Roche’s Xofluza is a novel drug that inhibits the endonuclease activity of the influenza virus. Zenara Pharma’s Paxzen is a combination of favipiravir and zinc acetate that enhances the antiviral effect6. Antiviral oral liquid can also be used for other indications, such as respiratory syncytial virus (RSV), cytomegalovirus (CMV), and dengue fever.
This report aims to provide a comprehensive presentation of the global market for Antiviral Oral Liquid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Oral Liquid.
The Antiviral Oral Liquid market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiviral Oral Liquid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiviral Oral Liquid companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Roche
Novartis
Merck
GlaxoSmithKline
Johnson & Johnson
AbbVie
Sanofi
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Novo Nordisk
Amgen
Gilead Sciences
CSL
Takeda Pharmaceuticals
Bayer
Celgene
Merck KGaA
Allergan
Segment by Type
Syrup
Oral suspension
Oral solution
Oral drop
Oral emulsion
Mixture
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiviral Oral Liquid company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiviral Oral Liquid Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Syrup
1.2.3 Oral suspension
1.2.4 Oral solution
1.2.5 Oral drop
1.2.6 Oral emulsion
1.2.7 Mixture
1.3 Market by Application
1.3.1 Global Antiviral Oral Liquid Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiviral Oral Liquid Market Perspective (2020-2031)
2.2 Global Antiviral Oral Liquid Growth Trends by Region
2.2.1 Global Antiviral Oral Liquid Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antiviral Oral Liquid Historic Market Size by Region (2020-2025)
2.2.3 Antiviral Oral Liquid Forecasted Market Size by Region (2026-2031)
2.3 Antiviral Oral Liquid Market Dynamics
2.3.1 Antiviral Oral Liquid Industry Trends
2.3.2 Antiviral Oral Liquid Market Drivers
2.3.3 Antiviral Oral Liquid Market Challenges
2.3.4 Antiviral Oral Liquid Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiviral Oral Liquid Players by Revenue
3.1.1 Global Top Antiviral Oral Liquid Players by Revenue (2020-2025)
3.1.2 Global Antiviral Oral Liquid Revenue Market Share by Players (2020-2025)
3.2 Global Antiviral Oral Liquid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antiviral Oral Liquid Revenue
3.4 Global Antiviral Oral Liquid Market Concentration Ratio
3.4.1 Global Antiviral Oral Liquid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiviral Oral Liquid Revenue in 2024
3.5 Global Key Players of Antiviral Oral Liquid Head office and Area Served
3.6 Global Key Players of Antiviral Oral Liquid, Product and Application
3.7 Global Key Players of Antiviral Oral Liquid, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiviral Oral Liquid Breakdown Data by Type
4.1 Global Antiviral Oral Liquid Historic Market Size by Type (2020-2025)
4.2 Global Antiviral Oral Liquid Forecasted Market Size by Type (2026-2031)
5 Antiviral Oral Liquid Breakdown Data by Application
5.1 Global Antiviral Oral Liquid Historic Market Size by Application (2020-2025)
5.2 Global Antiviral Oral Liquid Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antiviral Oral Liquid Market Size (2020-2031)
6.2 North America Antiviral Oral Liquid Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antiviral Oral Liquid Market Size by Country (2020-2025)
6.4 North America Antiviral Oral Liquid Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiviral Oral Liquid Market Size (2020-2031)
7.2 Europe Antiviral Oral Liquid Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antiviral Oral Liquid Market Size by Country (2020-2025)
7.4 Europe Antiviral Oral Liquid Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiviral Oral Liquid Market Size (2020-2031)
8.2 Asia-Pacific Antiviral Oral Liquid Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antiviral Oral Liquid Market Size by Region (2020-2025)
8.4 Asia-Pacific Antiviral Oral Liquid Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiviral Oral Liquid Market Size (2020-2031)
9.2 Latin America Antiviral Oral Liquid Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antiviral Oral Liquid Market Size by Country (2020-2025)
9.4 Latin America Antiviral Oral Liquid Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiviral Oral Liquid Market Size (2020-2031)
10.2 Middle East & Africa Antiviral Oral Liquid Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antiviral Oral Liquid Market Size by Country (2020-2025)
10.4 Middle East & Africa Antiviral Oral Liquid Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Antiviral Oral Liquid Introduction
11.1.4 Pfizer Revenue in Antiviral Oral Liquid Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Antiviral Oral Liquid Introduction
11.2.4 Roche Revenue in Antiviral Oral Liquid Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Antiviral Oral Liquid Introduction
11.3.4 Novartis Revenue in Antiviral Oral Liquid Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Antiviral Oral Liquid Introduction
11.4.4 Merck Revenue in Antiviral Oral Liquid Business (2020-2025)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Antiviral Oral Liquid Introduction
11.5.4 GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2020-2025)
11.5.5 GlaxoSmithKline Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Antiviral Oral Liquid Introduction
11.6.4 Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Antiviral Oral Liquid Introduction
11.7.4 AbbVie Revenue in Antiviral Oral Liquid Business (2020-2025)
11.7.5 AbbVie Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Antiviral Oral Liquid Introduction
11.8.4 Sanofi Revenue in Antiviral Oral Liquid Business (2020-2025)
11.8.5 Sanofi Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Antiviral Oral Liquid Introduction
11.9.4 Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2020-2025)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Antiviral Oral Liquid Introduction
11.10.4 AstraZeneca Revenue in Antiviral Oral Liquid Business (2020-2025)
11.10.5 AstraZeneca Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Antiviral Oral Liquid Introduction
11.11.4 Eli Lilly Revenue in Antiviral Oral Liquid Business (2020-2025)
11.11.5 Eli Lilly Recent Development
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Details
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Antiviral Oral Liquid Introduction
11.12.4 Novo Nordisk Revenue in Antiviral Oral Liquid Business (2020-2025)
11.12.5 Novo Nordisk Recent Development
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Antiviral Oral Liquid Introduction
11.13.4 Amgen Revenue in Antiviral Oral Liquid Business (2020-2025)
11.13.5 Amgen Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Antiviral Oral Liquid Introduction
11.14.4 Gilead Sciences Revenue in Antiviral Oral Liquid Business (2020-2025)
11.14.5 Gilead Sciences Recent Development
11.15 CSL
11.15.1 CSL Company Details
11.15.2 CSL Business Overview
11.15.3 CSL Antiviral Oral Liquid Introduction
11.15.4 CSL Revenue in Antiviral Oral Liquid Business (2020-2025)
11.15.5 CSL Recent Development
11.16 Takeda Pharmaceuticals
11.16.1 Takeda Pharmaceuticals Company Details
11.16.2 Takeda Pharmaceuticals Business Overview
11.16.3 Takeda Pharmaceuticals Antiviral Oral Liquid Introduction
11.16.4 Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2020-2025)
11.16.5 Takeda Pharmaceuticals Recent Development
11.17 Bayer
11.17.1 Bayer Company Details
11.17.2 Bayer Business Overview
11.17.3 Bayer Antiviral Oral Liquid Introduction
11.17.4 Bayer Revenue in Antiviral Oral Liquid Business (2020-2025)
11.17.5 Bayer Recent Development
11.18 Celgene
11.18.1 Celgene Company Details
11.18.2 Celgene Business Overview
11.18.3 Celgene Antiviral Oral Liquid Introduction
11.18.4 Celgene Revenue in Antiviral Oral Liquid Business (2020-2025)
11.18.5 Celgene Recent Development
11.19 Merck KGaA
11.19.1 Merck KGaA Company Details
11.19.2 Merck KGaA Business Overview
11.19.3 Merck KGaA Antiviral Oral Liquid Introduction
11.19.4 Merck KGaA Revenue in Antiviral Oral Liquid Business (2020-2025)
11.19.5 Merck KGaA Recent Development
11.20 Allergan
11.20.1 Allergan Company Details
11.20.2 Allergan Business Overview
11.20.3 Allergan Antiviral Oral Liquid Introduction
11.20.4 Allergan Revenue in Antiviral Oral Liquid Business (2020-2025)
11.20.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antiviral Oral Liquid Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Syrup
Table 3. Key Players of Oral suspension
Table 4. Key Players of Oral solution
Table 5. Key Players of Oral drop
Table 6. Key Players of Oral emulsion
Table 7. Key Players of Mixture
Table 8. Global Antiviral Oral Liquid Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Antiviral Oral Liquid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Antiviral Oral Liquid Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Antiviral Oral Liquid Market Share by Region (2020-2025)
Table 12. Global Antiviral Oral Liquid Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Antiviral Oral Liquid Market Share by Region (2026-2031)
Table 14. Antiviral Oral Liquid Market Trends
Table 15. Antiviral Oral Liquid Market Drivers
Table 16. Antiviral Oral Liquid Market Challenges
Table 17. Antiviral Oral Liquid Market Restraints
Table 18. Global Antiviral Oral Liquid Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Antiviral Oral Liquid Market Share by Players (2020-2025)
Table 20. Global Top Antiviral Oral Liquid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Oral Liquid as of 2024)
Table 21. Ranking of Global Top Antiviral Oral Liquid Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Antiviral Oral Liquid Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Antiviral Oral Liquid, Headquarters and Area Served
Table 24. Global Key Players of Antiviral Oral Liquid, Product and Application
Table 25. Global Key Players of Antiviral Oral Liquid, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antiviral Oral Liquid Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Antiviral Oral Liquid Revenue Market Share by Type (2020-2025)
Table 29. Global Antiviral Oral Liquid Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Antiviral Oral Liquid Revenue Market Share by Type (2026-2031)
Table 31. Global Antiviral Oral Liquid Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Antiviral Oral Liquid Revenue Market Share by Application (2020-2025)
Table 33. Global Antiviral Oral Liquid Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Antiviral Oral Liquid Revenue Market Share by Application (2026-2031)
Table 35. North America Antiviral Oral Liquid Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Antiviral Oral Liquid Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Antiviral Oral Liquid Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Antiviral Oral Liquid Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Antiviral Oral Liquid Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Antiviral Oral Liquid Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Antiviral Oral Liquid Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Antiviral Oral Liquid Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Antiviral Oral Liquid Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Antiviral Oral Liquid Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Antiviral Oral Liquid Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Antiviral Oral Liquid Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Antiviral Oral Liquid Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Antiviral Oral Liquid Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Antiviral Oral Liquid Market Size by Country (2026-2031) & (US$ Million)
Table 50. Pfizer Company Details
Table 51. Pfizer Business Overview
Table 52. Pfizer Antiviral Oral Liquid Product
Table 53. Pfizer Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Roche Company Details
Table 56. Roche Business Overview
Table 57. Roche Antiviral Oral Liquid Product
Table 58. Roche Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 59. Roche Recent Development
Table 60. Novartis Company Details
Table 61. Novartis Business Overview
Table 62. Novartis Antiviral Oral Liquid Product
Table 63. Novartis Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Merck Company Details
Table 66. Merck Business Overview
Table 67. Merck Antiviral Oral Liquid Product
Table 68. Merck Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 69. Merck Recent Development
Table 70. GlaxoSmithKline Company Details
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline Antiviral Oral Liquid Product
Table 73. GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 74. GlaxoSmithKline Recent Development
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Antiviral Oral Liquid Product
Table 78. Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 79. Johnson & Johnson Recent Development
Table 80. AbbVie Company Details
Table 81. AbbVie Business Overview
Table 82. AbbVie Antiviral Oral Liquid Product
Table 83. AbbVie Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 84. AbbVie Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Antiviral Oral Liquid Product
Table 88. Sanofi Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Bristol-Myers Squibb Company Details
Table 91. Bristol-Myers Squibb Business Overview
Table 92. Bristol-Myers Squibb Antiviral Oral Liquid Product
Table 93. Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 94. Bristol-Myers Squibb Recent Development
Table 95. AstraZeneca Company Details
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Antiviral Oral Liquid Product
Table 98. AstraZeneca Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 99. AstraZeneca Recent Development
Table 100. Eli Lilly Company Details
Table 101. Eli Lilly Business Overview
Table 102. Eli Lilly Antiviral Oral Liquid Product
Table 103. Eli Lilly Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 104. Eli Lilly Recent Development
Table 105. Novo Nordisk Company Details
Table 106. Novo Nordisk Business Overview
Table 107. Novo Nordisk Antiviral Oral Liquid Product
Table 108. Novo Nordisk Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 109. Novo Nordisk Recent Development
Table 110. Amgen Company Details
Table 111. Amgen Business Overview
Table 112. Amgen Antiviral Oral Liquid Product
Table 113. Amgen Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 114. Amgen Recent Development
Table 115. Gilead Sciences Company Details
Table 116. Gilead Sciences Business Overview
Table 117. Gilead Sciences Antiviral Oral Liquid Product
Table 118. Gilead Sciences Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 119. Gilead Sciences Recent Development
Table 120. CSL Company Details
Table 121. CSL Business Overview
Table 122. CSL Antiviral Oral Liquid Product
Table 123. CSL Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 124. CSL Recent Development
Table 125. Takeda Pharmaceuticals Company Details
Table 126. Takeda Pharmaceuticals Business Overview
Table 127. Takeda Pharmaceuticals Antiviral Oral Liquid Product
Table 128. Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 129. Takeda Pharmaceuticals Recent Development
Table 130. Bayer Company Details
Table 131. Bayer Business Overview
Table 132. Bayer Antiviral Oral Liquid Product
Table 133. Bayer Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 134. Bayer Recent Development
Table 135. Celgene Company Details
Table 136. Celgene Business Overview
Table 137. Celgene Antiviral Oral Liquid Product
Table 138. Celgene Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 139. Celgene Recent Development
Table 140. Merck KGaA Company Details
Table 141. Merck KGaA Business Overview
Table 142. Merck KGaA Antiviral Oral Liquid Product
Table 143. Merck KGaA Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 144. Merck KGaA Recent Development
Table 145. Allergan Company Details
Table 146. Allergan Business Overview
Table 147. Allergan Antiviral Oral Liquid Product
Table 148. Allergan Revenue in Antiviral Oral Liquid Business (2020-2025) & (US$ Million)
Table 149. Allergan Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Authors List of This Report
List of Figures
Figure 1. Antiviral Oral Liquid Picture
Figure 2. Global Antiviral Oral Liquid Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antiviral Oral Liquid Market Share by Type: 2024 VS 2031
Figure 4. Syrup Features
Figure 5. Oral suspension Features
Figure 6. Oral solution Features
Figure 7. Oral drop Features
Figure 8. Oral emulsion Features
Figure 9. Mixture Features
Figure 10. Global Antiviral Oral Liquid Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Antiviral Oral Liquid Market Share by Application: 2024 VS 2031
Figure 12. Adults Case Studies
Figure 13. Children Case Studies
Figure 14. Antiviral Oral Liquid Report Years Considered
Figure 15. Global Antiviral Oral Liquid Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Antiviral Oral Liquid Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Antiviral Oral Liquid Market Share by Region: 2024 VS 2031
Figure 18. Global Antiviral Oral Liquid Market Share by Players in 2024
Figure 19. Global Top Antiviral Oral Liquid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Oral Liquid as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Antiviral Oral Liquid Revenue in 2024
Figure 21. North America Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Antiviral Oral Liquid Market Share by Country (2020-2031)
Figure 23. United States Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Antiviral Oral Liquid Market Share by Country (2020-2031)
Figure 27. Germany Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Antiviral Oral Liquid Market Share by Region (2020-2031)
Figure 35. China Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Antiviral Oral Liquid Market Share by Country (2020-2031)
Figure 43. Mexico Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Antiviral Oral Liquid Market Share by Country (2020-2031)
Figure 47. Turkey Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Antiviral Oral Liquid Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Pfizer Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 55. Johnson & Johnson Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 56. AbbVie Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 57. Sanofi Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 59. AstraZeneca Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 60. Eli Lilly Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 61. Novo Nordisk Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 62. Amgen Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 63. Gilead Sciences Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 64. CSL Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 65. Takeda Pharmaceuticals Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 66. Bayer Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 67. Celgene Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 68. Merck KGaA Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 69. Allergan Revenue Growth Rate in Antiviral Oral Liquid Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
